{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:07:37Z","timestamp":1791230857048,"version":"4.1.0"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"1","funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,6,28]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Data on cellular immune responses in persons with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection following vaccination are limited. The evaluation of these patients with SARS-CoV-2 breakthrough infections may provide insight into how vaccinations limit the escalation of deleterious host inflammatory responses.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We conducted a prospective study of peripheral blood cellular immune responses to SARS-CoV-2 infection in 21 vaccinated patients, all with mild disease, and 97 unvaccinated patients stratified based on disease severity.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>We enrolled 118 persons (aged 50 years [SD 14.5 years], 52 women) with SARS-CoV-2 infection. Compared to unvaccinated patients, vaccinated patients with breakthrough infections had a higher percentage of antigen-presenting monocytes (HLA-DR+), mature monocytes (CD83+), functionally competent T cells (CD127+), and mature neutrophils (CD10+); and lower percentages of activated T cells (CD38+), activated neutrophils (CD64+), and immature B cells (CD127+CD19+). These differences widened with increased disease severity in unvaccinated patients. Longitudinal analysis showed that cellular activation decreased over time but persisted in unvaccinated patients with mild disease at 8-month follow-up.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Patients with SARS-CoV-2 breakthrough infections exhibit cellular immune responses that limit the progression of inflammatory responses and suggest mechanisms by which vaccination limits disease severity. These data may have implications for developing more effective vaccines and therapies.<\/jats:p>\n                  <jats:p>Clinical Trials Registration.\u2003NCT04401449.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/infdis\/jiad045","type":"journal-article","created":{"date-parts":[[2023,2,18]],"date-time":"2023-02-18T19:53:06Z","timestamp":1676749986000},"page":"46-58","source":"Crossref","is-referenced-by-count":18,"title":["Vaccination Ameliorates Cellular Inflammatory Responses in SARS-CoV-2 Breakthrough Infections"],"prefix":"10.1093","volume":"228","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8093-4855","authenticated-orcid":false,"given":"Julio A","family":"Huapaya","sequence":"first","affiliation":[{"name":"Critical Care Medicine Department, Clinical Center, National Institutes of Health , Bethesda, Maryland , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanette","family":"Higgins","sequence":"additional","affiliation":[{"name":"Applied and Developmental Research Directorate, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc. , Frederick, Maryland , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shreya","family":"Kanth","sequence":"additional","affiliation":[{"name":"Critical Care Medicine Department, Clinical Center, National Institutes of Health , Bethesda, Maryland , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cumhur Y","family":"Demirkale","sequence":"additional","affiliation":[{"name":"Critical Care Medicine Department, Clinical Center, National Institutes of Health , Bethesda, Maryland , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salina","family":"Gairhe","sequence":"additional","affiliation":[{"name":"Critical Care Medicine Department, Clinical Center, National Institutes of Health , Bethesda, Maryland , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etsubdink A","family":"Aboye","sequence":"additional","affiliation":[{"name":"Medstar Heart and Vascular Institute, Medstar Washington Hospital Center , Washington, District of Columbia , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Regenold","sequence":"additional","affiliation":[{"name":"Critical Care Medicine Department, Clinical Center, National Institutes of Health , Bethesda, Maryland , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seynt Jiro","family":"Sahagun","sequence":"additional","affiliation":[{"name":"Critical Care Medicine Department, Clinical Center, National Institutes of Health , Bethesda, Maryland , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Pastor","sequence":"additional","affiliation":[{"name":"Critical Care Medicine Department, Clinical Center, National Institutes of Health , Bethesda, Maryland , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doris","family":"Swaim","sequence":"additional","affiliation":[{"name":"Critical Care Medicine Department, Clinical Center, National Institutes of Health , Bethesda, Maryland , USA"},{"name":"Applied and Developmental Research Directorate, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc. , Frederick, Maryland , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Dewar","sequence":"additional","affiliation":[{"name":"Virus Isolation and Serology Laboratory, Frederick National Laboratory, Applied and Developmental Directorate , Frederick, Maryland , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tauseef","family":"Rehman","sequence":"additional","affiliation":[{"name":"Virus Isolation and Serology Laboratory, Frederick National Laboratory, Applied and Developmental Directorate , Frederick, Maryland , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helene C","family":"Highbarger","sequence":"additional","affiliation":[{"name":"Virus Isolation and Serology Laboratory, Frederick National Laboratory, Applied and Developmental Directorate , Frederick, Maryland , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Perrine","family":"Lallemand","sequence":"additional","affiliation":[{"name":"Virus Isolation and Serology Laboratory, Frederick National Laboratory, Applied and Developmental Directorate , Frederick, Maryland , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvain","family":"Laverdure","sequence":"additional","affiliation":[{"name":"Laboratory of Human Retrovirology and Immunoinformatics, Frederick National Laboratory, Applied and Developmental Directorate , Frederick, Maryland , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Adelsberger","sequence":"additional","affiliation":[{"name":"Applied and Developmental Research Directorate, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc. , Frederick, Maryland , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Rupert","sequence":"additional","affiliation":[{"name":"AIDS Monitoring Laboratory, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc. , Frederick, Maryland , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willy","family":"Li","sequence":"additional","affiliation":[{"name":"Pharmacy Department, Clinical Center, National Institutes of Health , Bethesda, Maryland , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janell","family":"Krack","sequence":"additional","affiliation":[{"name":"Pharmacy Department, Clinical Center, National Institutes of Health , Bethesda, Maryland , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gebeyehu","family":"Teferi","sequence":"additional","affiliation":[{"name":"Unity Health Care , Washington, District of Columbia , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janaki","family":"Kuruppu","sequence":"additional","affiliation":[{"name":"Critical Care Medicine Department, Clinical Center, National Institutes of Health , Bethesda, Maryland , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey R","family":"Strich","sequence":"additional","affiliation":[{"name":"Critical Care Medicine Department, Clinical Center, National Institutes of Health , Bethesda, Maryland , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Davey","sequence":"additional","affiliation":[{"name":"Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health , Bethesda, Maryland , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Childs","sequence":"additional","affiliation":[{"name":"Laboratory of Transplantation Immunotherapy, Cellular and Molecular Therapeutics Branch, National Heart Lung and Blood Institute, National Institutes of Health , Bethesda, Maryland , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Chertow","sequence":"additional","affiliation":[{"name":"Critical Care Medicine Department, Clinical Center, National Institutes of Health , Bethesda, Maryland , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph A","family":"Kovacs","sequence":"additional","affiliation":[{"name":"Critical Care Medicine Department, Clinical Center, National Institutes of Health , Bethesda, Maryland , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Barnett","sequence":"additional","affiliation":[{"name":"Medstar Heart and Vascular Institute, Medstar Washington Hospital Center , Washington, District of Columbia , USA"},{"name":"Division of Cardiology, University of California San Francisco , San Francisco, California , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parizad","family":"Torabi-Parizi","sequence":"additional","affiliation":[{"name":"Critical Care Medicine Department, Clinical Center, National Institutes of Health , Bethesda, Maryland , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4179-0902","authenticated-orcid":false,"given":"Anthony F","family":"Suffredini","sequence":"additional","affiliation":[{"name":"Critical Care Medicine Department, Clinical Center, National Institutes of Health , Bethesda, Maryland , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the COVID-ARC Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Purdy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl","family":"Chairez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"McClaughlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Dee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kara A","family":"Curl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocco","family":"Caldararo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Rehm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulisses","family":"Santamaria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Giles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabil","family":"Fallouh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"DeVille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa","family":"Moriarity","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane Boyom","family":"Pouomogne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Gonzales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aarthi","family":"Shenoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,2,18]]},"reference":[{"key":"2023062813221923000_jiad045-B1","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1007\/s10875-020-00806-6","article-title":"Flow cytometry identifies risk factors and dynamic changes in patients with COVID-19","volume":"40","author":"Moratto","year":"2020","journal-title":"J Clin Immunol"},{"key":"2023062813221923000_jiad045-B2","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103622","article-title":"Severe COVID-19 is characterized by the co-occurrence of moderate cytokine inflammation and severe monocyte dysregulation","volume":"73","author":"Bonnet","year":"2021","journal-title":"EBioMedicine"},{"key":"2023062813221923000_jiad045-B3","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.735125","article-title":"Persistent high percentage of HLA-DR+CD38highCD8+ T cells associated with immune disorder and disease severity of COVID-19","volume":"12","author":"Du","year":"2021","journal-title":"Front Immunol"},{"key":"2023062813221923000_jiad045-B4","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.861666","article-title":"Activated CD8+CD38+ cells are associated with worse clinical outcome in hospitalized COVID-19 patients","volume":"13","author":"Bobcakova","year":"2022","journal-title":"Front Immunol"},{"key":"2023062813221923000_jiad045-B5","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.655934","article-title":"T cell activation, highly armed cytotoxic cells and a shift in monocytes CD300 receptors expression is characteristic of patients with severe COVID-19","volume":"12","author":"Zenarruzabeitia","year":"2021","journal-title":"Front Immunol"},{"key":"2023062813221923000_jiad045-B6","doi-asserted-by":"crossref","first-page":"5243","DOI":"10.1038\/s41467-020-19080-6","article-title":"Whole blood immunophenotyping uncovers immature neutrophil-to-VD2 T-cell ratio as an early marker for severe COVID-19","volume":"11","author":"Carissimo","year":"2020","journal-title":"Nat Commun"},{"key":"2023062813221923000_jiad045-B7","doi-asserted-by":"crossref","first-page":"22463","DOI":"10.1038\/s41598-021-01943-7","article-title":"DEspRhigh neutrophils are associated with critical illness in COVID-19","volume":"11","author":"deKay","year":"2021","journal-title":"Sci Rep"},{"key":"2023062813221923000_jiad045-B8","article-title":"Single-cell analysis reveals the immune characteristics of myeloid cells and memory T cells in recovered COVID-19 patients with different severities","volume":"12","author":"Li","year":"2021","journal-title":"Front Immunol"},{"key":"2023062813221923000_jiad045-B9","doi-asserted-by":"crossref","first-page":"9228","DOI":"10.3390\/ijms22179228","article-title":"SARS-CoV-2 impairs dendritic cells and regulates DC-SIGN gene expression in tissues","volume":"22","author":"Cai","year":"2021","journal-title":"Int J Mol Sci"},{"key":"2023062813221923000_jiad045-B10","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.cell.2022.01.011","article-title":"SARS-CoV-2 breakthrough infections elicit potent, broad, and durable neutralizing antibody responses","volume":"185","author":"Walls","year":"2022","journal-title":"Cell"},{"key":"2023062813221923000_jiad045-B11","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abn6150","article-title":"Characterization of immune responses in fully vaccinated individuals after breakthrough infection with the SARS-CoV-2 Delta variant","volume":"14","author":"Collier","year":"2022","journal-title":"Sci Transl Med"},{"key":"2023062813221923000_jiad045-B12","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abn8014","article-title":"Vaccination before or after SARS-CoV-2 infection leads to robust humoral response and antibodies that effectively neutralize variants","volume":"7","author":"Bates","year":"2022","journal-title":"Sci Immunol"},{"key":"2023062813221923000_jiad045-B13","doi-asserted-by":"crossref","first-page":"206","DOI":"10.15585\/mmwr.mm7106a4","article-title":"Genomic surveillance for SARS-CoV-2 variants: predominance of the Delta (B.1.617.2) and Omicron (B.1.1.529) variants\u2014United States, June 2021\u2013January 2022","volume":"71","author":"Lambrou","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2023062813221923000_jiad045-B14","author":"Hodcroft"},{"key":"2023062813221923000_jiad045-B15","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1001\/jama.286.14.1754","article-title":"Serial evaluation of the SOFA score to predict outcome in critically ill patients","volume":"286","author":"Ferreira","year":"2001","journal-title":"JAMA"},{"key":"2023062813221923000_jiad045-B16","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"2023062813221923000_jiad045-B17","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1214\/aos\/1013699998","article-title":"The control of the false discovery rate in multiple testing under dependency","volume":"29","author":"Benjamini","year":"2001","journal-title":"Ann Stat"},{"key":"2023062813221923000_jiad045-B18","doi-asserted-by":"crossref","DOI":"10.1126\/science.abc8511","article-title":"Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications","volume":"369","author":"Mathew","year":"2020","journal-title":"Science"},{"key":"2023062813221923000_jiad045-B19","doi-asserted-by":"crossref","first-page":"3434","DOI":"10.1038\/s41467-020-17292-4","article-title":"Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia","volume":"11","author":"De Biasi","year":"2020","journal-title":"Nat Commun"},{"key":"2023062813221923000_jiad045-B20","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/nyas.14333","article-title":"Myeloid cells in sepsis-acquired immunodeficiency","volume":"1499","author":"Venet","year":"2021","journal-title":"Ann N Y Acad Sci"},{"key":"2023062813221923000_jiad045-B21","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/s41590-017-0022-x","article-title":"Myeloid-derived suppressor cells coming of age","volume":"19","author":"Veglia","year":"2018","journal-title":"Nat Immunol"},{"key":"2023062813221923000_jiad045-B22","doi-asserted-by":"crossref","first-page":"721","DOI":"10.3389\/fimmu.2020.00721","article-title":"The CD83 molecule\u2014an important immune checkpoint","volume":"11","author":"Grosche","year":"2020","journal-title":"Front Immunol"},{"key":"2023062813221923000_jiad045-B23","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.3389\/fimmu.2019.01312","article-title":"CD83: activation marker for antigen presenting cells and its therapeutic potential","volume":"10","author":"Li","year":"2019","journal-title":"Front Immunol"},{"key":"2023062813221923000_jiad045-B24","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.jmb.2017.03.009","article-title":"Crystal structure of the extracellular domain of the human dendritic cell surface marker CD83","volume":"429","author":"Heilingloh","year":"2017","journal-title":"J Mol Biol"},{"key":"2023062813221923000_jiad045-B25","doi-asserted-by":"crossref","first-page":"18778","DOI":"10.1073\/pnas.1018994108","article-title":"CD83-stimulated monocytes suppress T-cell immune responses through production of prostaglandin E2","volume":"108","author":"Chen","year":"2011","journal-title":"Proc Natl Acad Sci"},{"key":"2023062813221923000_jiad045-B26","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/j.cell.2020.08.001","article-title":"Severe COVID-19 is marked by a dysregulated myeloid cell compartment","volume":"182","author":"Schulte-Schrepping","year":"2020","journal-title":"Cell"},{"key":"2023062813221923000_jiad045-B27","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.smim.2012.04.010","article-title":"IL-7 signaling and CD127 receptor regulation in the control of T cell homeostasis","volume":"24","author":"Carrette","year":"2012","journal-title":"Semin Immunol"},{"key":"2023062813221923000_jiad045-B28","doi-asserted-by":"crossref","first-page":"5926","DOI":"10.4049\/jimmunol.174.10.5926","article-title":"Cutting edge: emergence of CD127high functionally competent memory T cells is compromised by high viral loads and inadequate T cell help","volume":"174","author":"Fuller","year":"2005","journal-title":"J Immunol"},{"key":"2023062813221923000_jiad045-B29","article-title":"SARS-CoV-2-specific T cells exhibit phenotypic features of helper function, lack of terminal differentiation, and high proliferation potential","volume":"1","author":"Neidleman","year":"2020","journal-title":"Cell Rep Med"},{"key":"2023062813221923000_jiad045-B30","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109414","article-title":"Distinctive features of SARS-CoV-2-specific T cells predict recovery from severe COVID-19","volume":"36","author":"Neidleman","year":"2021","journal-title":"Cell Rep"},{"key":"2023062813221923000_jiad045-B31","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.cyto.2009.12.001","article-title":"IL-7 receptor is expressed on adult pre-B-cell acute lymphoblastic leukemia and other B-cell derived neoplasms and correlates with expression of proliferation and survival markers","volume":"50","author":"Sasson","year":"2010","journal-title":"Cytokine"},{"key":"2023062813221923000_jiad045-B32","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/s41590-021-01104-y","article-title":"Pathological sequelae of long-haul COVID","volume":"23","author":"Mehandru","year":"2022","journal-title":"Nat Immunol"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jid\/advance-article-pdf\/doi\/10.1093\/infdis\/jiad045\/49481528\/jiad045.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/228\/1\/46\/50730761\/jiad045.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/228\/1\/46\/50730761\/jiad045.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T13:23:12Z","timestamp":1687958592000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/228\/1\/46\/7046024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,18]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,2,18]]},"published-print":{"date-parts":[[2023,6,28]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiad045","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,7,1]]},"published":{"date-parts":[[2023,2,18]]}}}